Impaired mitochondrial response to simulated ischemic injury as a predictor of the development of atrial fibrillation after cardiac surgery: In vitro study in human myocardium  by Ad, Niv et al.
Ad et al Cardiopulmonary Support and Physiology
CS
PImpaired mitochondrial response to simulated ischemic
injury as a predictor of the development of atrial
fibrillation after cardiac surgery: In vitro study in human
myocardium
Niv Ad, MDa
Aviva Schneider, MScb
Igor Khaliulin, PhDb
Joseph B. Borman, MDbHerzl Schwalb, PhDbFrom The Department of Cardiothoracic
Surgerya and The Joseph Lunenfeld Car-
diac Surgery Research Center,b Hadassah
University Hospital, Jerusalem, Israel.
Received for publication Sept 5, 2003; re-
visions requested March 15, 2004; accepted
for publication March 25, 2004.
Address for reprints: Niv Ad, MD, Cardio-
thoracic Surgery Department, Hadassah
University Hospital, Jerusalem 91120, Is-
rael (E-mail: nivadmd@hotmail.com).
J Thorac Cardiovasc Surg 2005;129:41-5
0022-5223/$30.00
Copyright © 2005 by The American Asso-
ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2004.03.058Objective: Atrial fibrillation occurs in 20% to 40% of patients after cardiac surgery,
but its pathophysiology remains unclear. Recent studies demonstrated preexisting
histologic markers that portend the development of postoperative atrial fibrillation.
In this prospective study, we focused on mitochondrial dysfunction in response to
ischemic stress as a potential predictor for postoperative atrial fibrillation.
Methods: Slices of right atrial trabeculae from 50 patients undergoing elective
cardiac surgery were surperfused with oxygenated glucose-containing phosphate-
buffered saline solution. After 30 minutes of stabilization, the sections were exposed
to 90 minutes of simulated ischemia (nitrogenated phosphate-buffered saline solu-
tion without glucose) followed by 90 minutes of reoxygenation (reintroduction of
the oxygenated solution). Mitochondrial viability and response were measured by
staining with 3-[4.5 dimethylthiazol 2-yl]-2,5-diphenyltetrazolium bromide. The
magnitudes of mitochondrial recovery after simulated ischemia and 28 possible risk
factors for postoperative atrial fibrillation were entered into univariate and multi-
variate models.
Results: There were no deaths in this group of patients. Nineteen patients (38%) had
postoperative atrial fibrillation. Interestingly, no difference in baseline (before
simulated ischemia) mitochondrial function was documented between patients who
had postoperative atrial fibrillation and those who did not. An independent predictor
for postoperative atrial fibrillation was the degree of mitochondrial dysfunction in
response to simulated ischemia, as measured by the intensity of the staining.
Conclusion: This study has identified for the first time an association between
mitochondrial dysfunction in response to ischemia and postoperative atrial fibrilla-
tion. This finding improves our understanding of the pathophysiology of postoper-
ative atrial fibrillation and may eventually lead us to identify candidates for selective
preoperative or early postoperative prophylactic treatment.
Atrial fibrillation is a common complication in cardiac surgery,occurring within the first week after operation in 20% to 40% ofthe patients undergoing cardiac surgery, and its incidence may beincreasing.1 Although often regarded as a temporary, benignproblem, this complication has significant adverse effects: it in-creases the risk of cerebrovascular accident and extends intensive
care unit and hospital stays.2,3
The Journal of Thoracic and Cardiovascular Surgery ● Volume 129, Number 1 41
Cardiopulmonary Support and Physiology Ad et al
CSPThe mechanism for the development of postoperative
atrial fibrillation (POAF) is unclear. It is known that POAF
involves reentry, resulting from disparate refractoriness be-
tween adjacent atrial areas,4 but the reasons for these dis-
similarities are unknown. Risk factors associated with the
development of POAF include advanced age, prolonged
preoperative atrial conduction duration, chronic obstructive
pulmonary disease, excess circulating catecholamines, elec-
trolyte imbalance, atrial myocardial ischemia, sudden
-blocker withdrawal, prolonged aortic crossclamping, and
right atrial manipulation.1-7 One of the confusing aspects of
POAF is the fact that it does not develop in roughly 60% of
patients having cardiac surgery, despite the presence of one
or more of these risk factors in nearly all of them, suggest-
ing an inherent preoperative risk of postoperative develop-
ment in a subgroup of patients. This may be specifically
suggested by the finding that prolonged preoperative atrial
conduction duration is associated with POAF.6 It has pre-
viously been shown that high lipofuscin content and atrial
myolysis found in atria before cardiopulmonary bypass
(CPB) may also be associated with vulnerability to
POAF.8,9 Taken together, these factors indicate that the
preoperative status of a patient’s atria is a major determinant
of the risk of development of POAF, in addition to the stress
and ischemia induced by the surgical procedure itself.
The association between advanced age and risk of atrial
fibrillation after cardiac surgery is striking but specifically
unclear. It has been attributed to age-related atrial changes
such as atrophy and fibrosis,1,10 but this association has
never been directly examined.
Susceptibility to POAF may depend on the preoperative
metabolic status of the atria, and this may be reflected by the
mitochondrial response to postischemic reperfusion injury.
Directly or indirectly, mitochondria are important targets
for virtually all types of injurious stimuli, including hypoxia
and toxins. The damage is commonly expressed as the
formation of high-conductance channels, the so-called mi-
tochondrial permeability transition. This, together with find-
ings of an association between deletion of mitochondrial
TABLE 1. Characteristics of the study group (n  50)
Characteristic Value
Age (y, mean  SD) 59.3 10.6
Male/female ratio 2:1
Coronary artery bypass grafting (No.) 31
Aortic valve replacement (No.) 10
Aortic valve replacement plus coronary artery bypass
grafting (No.)
2
Mitral valve surgery (No.) 5
Mitral valve surgery plus coronary artery bypass
grafting (No.)
2DNA aging and atrial fibrillation, has led to the assumption
42 The Journal of Thoracic and Cardiovascular Surgery ● Januathat impaired mitochondrial function in atrial cardiomyo-
cytes may be related to atrial fibrillation after cardiac sur-
gery.11,12 This study was designed to examine mitochon-
drial function in response to simulated ischemia-reperfusion
(I/R) stress as a potential predictor for the development of
atrial fibrillation after surgery.
Methods
Tissue Preparation
The investigation conformed to the principles outlined in the
Helsinki Declaration. Approval to conduct the study was obtained
from the institutional ethics committee on human research (Janu-
ary 2002).
Right atrial appendages were obtained from 50 patients under-
going elective cardiac surgery with CPB, but before CPB was
initiated (Table 1). The protocol in use for simulated I/R of isolated
human atrial sections was adopted from studies by Ghosh and
colleagues.13 The specimens were placed in test tubes containing
oxygenated, heparinized samples of patients’ blood and immedi-
ately transferred to the laboratory. The specimens were rinsed with
glucose-containing phosphate-buffered saline solution (G-PBS),
and trabeculae were gently separated longitudinally.
Incubation medium. G-PBS (pH 7.45) was prepared daily in
distilled water and contained the following: 136.9-mmol/L sodium
chloride, 2.68-mmol/L potassium chloride, 8.10-mmol/L dibasic
sodium phosphate, 1.53-mmol/L monobasic potassium phosphate,
0.5-mmol/L magnesium chloride hexahydrate, 0.9-mmol/L cal-
cium chloride dihydrate, and 5.55-mmol/L glucose.
Staining solution. The 3-[4,5-dimethythiazol-2-yl]-2,5-diphe-
nyltetrazolium bromide (MTT) and diazoxide were obtained from
Sigma Chemical Co. The MTT staining solution was prepared by
dissolving 0.5 mg MTT in 1 mL G-PBS.
Simulated I/R
Initially, atrial sections (5-10 mg each) were placed in containers
with 20 mL G-PBS and incubated for 30 minutes for equilibration
at 37°C in a cell culture incubator. After aerobic equilibration, the
study sections were rinsed in phosphate buffered saline solution
without glucose (PBS) and subjected to I/R, whereas the aerobic
control sections remained in the incubator in oxygenated G-PBS
for the entire experiment. Ischemia (37°C) was simulated by
placing the sections (2 sections per 35-mm culture plate) in a
sealed Plexiglas (Elf Atochem North America, Inc, Philadelphia,
Pa) chamber (Figure 1).14 The chamber was vigorously flushed
with 100% nitrogen for 5 minutes to replace the oxygen with
nitrogen. En route to the chamber, the gas passed two traps: trap 1
contained 1% sodium sulfite and trap 2 contained water. A 2-mL
syringe, flushed with nitrogen, was filled with ischemic PBS
(without glucose, bubbled for 1 hour with nitrogen). Each well was
quickly filled with 0.4 mL ischemic PBS (minimal volume to
cover the slices) and corked. The flow of nitrogen was attenu-
ated to approximately 1 bubble/s at the exit trap, and the
ischemia was maintained for 90 minutes. At the end of 90
minutes of simulated ischemia, the slices were subjected to 90
minutes of reoxygenation in oxygenated G-PBS at 37°C in a
100% oxygenated environment.
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PAssessment of Tissue Injury and Viability
At the end of each experimental protocol, tissue viability was
determined by MTT staining. The reduction of MTT to blue
formazan is catalyzed by mitochondrial dehydrogenases, and the
intensity of MTT staining in myocardial sections is correlated with
the viability of the tissue.14
MTT was present for the entire period of the reoxygenation.
Two atrial sections were incubated in 1 mL G-PBS containing
MTT (0.5 mg/mL) at 37°C for 90 minutes. The sections were then
transferred to a small test tube containing 3 mL saline solution and
shaken for 1 minute to remove excess dye. The sections were
wiped on gauze cloth and transferred to 1.5-mL plastic test tubes
and frozen overnight. Extraction of the formazan dye into 1 mL
dimethylsulfoxide was done with vigorous shaking for 1 hour at
37°C. The colored supernatant was measured spectrophotometri-
cally at 500 nm. The sections were dried in a 90°C oven for 24
hours. Staining results were expressed as optical density/mg dry
weight of myocardial tissue. Tissue viability was expressed as the
ratio between the I/R optical density and that of the aerobic control
specimens normalized to dry weight of myocardial tissue.
Statistical Analysis
The distribution of all variables was compared between patients
who had POAF and those who did not, with the Fisher exact test
used for discrete variables and Student t test for continuous vari-
ables. Data are expressed as mean  SD. Multiple logistic regres-
sion analysis for variables with statistical significance in the uni-
variate model was performed to determine the independent
predictors for POAF. All statistical analyses were performed with
Statistical Package for the Social Sciences version 10.0 (SPSS Inc,
Chicago, Ill).
Results
There were no perioperative deaths in this group of patients.
Nineteen patients (38%) had POAF, developing between
postoperative day 1 and postoperative day 5 (median post-
Figure 1. Sealedoperative day 3). The mitochondrial function, recorded from
The Journal of Thoracright atrial slices that were collected and kept under normal
conditions (aerobic control baseline function; Figure 2),
revealed no significant differences between atrial slices col-
lected from patients who had POAF and those who did not
(0.62  0.12 vs 0.64  0.08, P  .05).
Interestingly, a significant difference was documented
between the two groups of patients after the simulated I/R
phase. Atrial slices obtained from patients who had POAF
exhibited a significantly impaired mitochondrial function
and response to simulated I/R than did those from patients
with no POAF (0.19  0.06 vs 0.26  0.05, P  .003;
Figure 2). The ratio between the mitochondrial function
after simulated I/R and the baseline values (aerobic control)
represented an even more profound difference between the
groups of patients (28.8  9% vs 39.2  14%, P  .001;
Figure 3). In a univariate model (Table 2), the significant
variables related to POAF (P .05) were as follows: female
gender, right coronary artery disease, type of surgery (coronary
artery bypass grafting or aortic valve replacement), nonuse of
-blockers, MTT staining after I/R, and ratio between MTT
staining after I/R and baseline performance. In multivariate
analysis the only variable significant as predictor for POAF
was the ratio between MTT staining after I/R and baseline
(P  .027 in multivariate analysis). The classification table
(Table 3) based on the logistic regression analysis model
demonstrates relatively high predictive accuracy for POAF,
with a specificity of 89.7% and a sensitivity of 85%. There
is, however, a need for a much larger group of patients to
establish the real predictive value of the MTT staining test.
No correlation was found between MTT staining and
ratio (I/R to baseline) and other clinical factors such as age,
chronic obstructive pulmonary disease, diabetes, extent of
cardiac disease, type of operation, CPB time, or crossclamp
iglas chamber.time (P  .05).
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Recent reports have shown that POAF constitutes a major
clinical problem and may lead to severe sequelae and high
costs. Risk factors have been identified and may assist in
defining a group of patients who are at a greater risk for this
common complication.1-3 Until now, however, this progress
has not been reflected in any treatment regimen, and all
patients in a given institution get similar preoperative and
postoperative preventive antiarrhythmic treatment, irrespec-
tive of risk of POAF and with minimal success in reducing
its incidence. A possible reason for this discrepancy is our
lack of comprehension of the molecular and metabolic
processes involved.
MTT has the property of acting as hydrogen acceptor to
be reduced by dehydrogenases enzymes. MTT reduction of
a viable tissue is related also to the presence of coenzymes
nicotinamide adenine dinucleotide and nicotinamide ade-
nine dinucleotide phosphate. It is a simple and reliable
method correlated with ischemic damage and mitochondrial
dysfunction in both atrial and ventricular myocardium. In
addition, MTT assay can be used to assess myocardial
oxygen consumption and energetic index.15 Studies have
shown that oxidative stress may lead to compromised mi-
tochondrial redox function as indicated by the MTT as-
Figure 2. Mitochondrial response to simulated I/R injury. OD,
Optical density; I/R, ischemic reperfusion; POAF, postoperative
atrial fibrillation. Asterisk indicates P  .003.
Figure 3. Mitochondrial function ratio between after simulated
I/R and baseline aerobic control. I/R, Ischemic reperfusion; POAF,
postoperative atrial fibrillation. Asterisk indicates P  .001.say.13,16,17
44 The Journal of Thoracic and Cardiovascular Surgery ● JanuaThis study has pointed out for the first time an associa-
tion between POAF and mitochondrial dysfunction in re-
sponse to simulated I/R. It has demonstrated that impaired
response of right atrial mitochondria to simulated I/R may
predict the development of POAF. Several studies have
shown that ischemia or hypoxia followed by reperfusion
causes loss of both cytosolic and mitochondrial glutathione,
TABLE 2. Univariate analysis
Variable P value
Age .756
Gender .005
Chronic obstructive pulmonary disease .335
Smoking .587
Hypertension .745
Diabetes mellitus .506
Hypercholesterolemia .851
Acute myocardial infarction .087
Right coronary artery disease .0001
Incomplete revascularization of both systems .303
Incomplete revascularization of left coronary system .403
Incomplete revascularization of right coronary
system
.303
Ejection fraction .09
Congestive heart failure .931
Renal failure .229
Coronary artery bypass grafting .0001
Aortic valve replacement .019
Mitral valve repair .465
Mitral valve replacement .46
CPB time .32
Crossclamp time .16
History of atrial fibrillation .737
Preoperative use of -blockers .554
Preoperative use of angiotensin-converting enzyme
inhibitors
.729
Preoperative use of oral antiglycemic drugs .973
Preoperative use of statins .755
Preoperative use of digoxin .331
Nonuse of -blockers after operation .05
MTT staining
Control .77
After I/R .035
I/R to baseline ratio .015
TABLE 3. Classification table for POAF
Observed POAF
Predicted according to logistic regression
model
POAF Percentage
correctedNo Yes
No 26 3 89.7%
Yes 3 17 85%
The cut value was 0.5. One patient was dropped from the model because
of a missing variable.resulting in lack of recovery of contractile activity.18,19 The
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Pfinding of an association between deletion of mitochondrial
DNA aging and atrial fibrillation has led to the assumption
that impaired mitochondrial function in cardiomyocytes
may be related to atrial fibrillation and aging.11 Such a
process leads to bioenergetic deficiency as a result of im-
paired synthesis in the human atrium. Other studies have
shown the association between atrial fibrillation and im-
paired mitochondrial function in the atrium and alteration in
specific adenosine triphosphatase activity, energy metabo-
lism, and upregulation of heart failure markers such as
endothelin 1 and atrial natriuretic peptide.11,20 Another re-
port has revealed that mitochondrial dysfunction in the
cardiomyocytes may cause impairment of cellular energy
metabolism and induced apoptosis.21-23 It is therefore rea-
sonable to hypothesize that susceptibility to POAF may
depend on the preoperative metabolic status of the atria and
mitochondrial function and that it might be predictable on
the basis of morphologic parameters in preoperative histo-
logic atrial specimens and mitochondrial function.
The incidence of atrial fibrillation after off-pump coro-
nary artery bypass grafting surgery is not lower than that
after surgery performed with the use of a heart-lung ma-
chine. This finding, coupled with the fact that in this study
the model was predicted for patients after surgery for valve
disease as well as coronary artery bypass grafting, encour-
ages us to support the assumption that this complication is
not directly related to the type of surgery or the operative
technique but rather to preoperative atrial pathology that is
the result of the disease process in a given patient.
Our study has obvious limitations. Its size is limited, and
no mechanism to explain the findings has been suggested.
Because of the small size, classic parameters involved with
POAF such as age and chronic obstructive pulmonary dis-
ease did not reach statistical significance. However, it dem-
onstrates an important phenomenon, namely that POAF is
associated with mitochondrial dysfunction in response to
simulated I/R injury. It has been well discussed in many
articles that mitochondria are involved in the ultrastructural
changes appearing in the myocardial cells as consequence
of oxygen deprivation. Mitochondrial protection during I/R
or better mitochondrial function in response to such insult
may therefore result in improved myocardial function and
may also have antiarrhythmic effect. Studies are now re-
quired to dissect the molecular events and changes in gene
expression that lead to the increased susceptibility. Such
studies may also enhance the identification of preoperative
treatments to improve the preoperative metabolic status of
the atrial cells and reduce the risk for POAF.
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